# Syndax Pharmaceuticals Inc. (SNDX) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$273M |
| 2024 | -$340M |
| 2023 | -$230M |
| 2022 | -$152M |
| 2021 | $26M |
| 2020 | -$71M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | -$34M |
| 2025-12-31 | -$63M |
| 2025-09-30 | -$57M |
| 2025-06-30 | -$69M |
| 2025-03-31 | -$84M |
| 2024-12-31 | -$96M |

Source: [CompaniesByCap](https://companiesbycap.com/company/SNDX/operating-income)